Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_15155 | 24 | 0.50 | Mlig455_036661 | Neo: - Age: - |
Mlig455_036661 {REF} {Length: 2246} {TRANSSPLICED} {RNA1310_29694.1} {RNA815_29887} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -2.72 | 0.939 | 0.99970 | 1.00000 | |
RegionR2 | -0.908 | 0.939 | 0.93790 | 1.00000 | |
RegionR3 | 1.015 | 0.939 | 0.50528 | 0.99686 | |
RegionR4 | 1.09 | 0.939 | 0.56919 | 0.88762 | |
RegionR5 | 1.377 | 0.939 | 0.40314 | 0.76081 | |
RegionR6 | 0.341 | 0.939 | 0.71327 | 1.00000 | |
RegionR7 | 2.548 | 0.939 | 0.17786 | 0.77306 | |
RegionR8 | -2.743 | 0.939 | 1.00000 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.409 | 0.939 | 1.00000 | 1.00000 | |
RegenerationR2 | 1.248 | 0.939 | 0.49364 | 0.86869 | |
RegenerationR3 | -0.495 | 0.939 | 0.78382 | 0.97692 | |
RegenerationR4 | -0.706 | 0.939 | 0.74089 | 0.96769 | |
RegenerationR5 | -1.356 | 0.939 | 0.46669 | 0.84043 | |
RegenerationR6 | -1.395 | 0.939 | 0.51952 | 0.82029 | |
RegenerationBL | -2.891 | 0.939 | 1.00000 | 1.00000 | |
RegenerationTP | -2.659 | 0.939 | 0.99977 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_15155 | 24 | 0.5 | Mlig455_036661 | Neo: - Age: - |
2 | - | 1.000 | - | - | 1.000 | - | Mlig455_036661 {REF} {Length: 2246} {TRANSSPLICED} {RNA1310_29694.1} {RNA815_29887} | |
2. | MligTC455_32027 | 16 | 0.34 | Mlig455_035199 | Neo: - Age: - Region-enriched R7: 5.354/0.00914 |
SETMAR | 0.992 | - | - | - | - | 0.992 | - | Mlig455_035199 {REF} {Length: 1470} {Pfam: DDE superfamily endonuclease [PF13358.8, score=37.1]; Homeodomain-like domain [PF13565.8, score=27.8]; Helix-turn-helix domain (DUF4817) [PF16087.7, score=24.9]; HTH domain in Mos1 transposase [PF17906.3, score=21.1]; Transposase [PF01498.20, score=18.9]} {Human: ENSG00000170364, SETMAR, SET domain and mariner transposase fusion gene, [Score=95.9, Expect=4e-21]} {Smed: dd_Smed_v6_14929_0_1, dd_Smed_v6_14929_0_1, [RH, Score=64.7, Expect=6e-13]} {RNA1509_9634} {RNA1310_4459.1} {RNA815_18810} |
3. | MligTC455_28393 | 77 | 1.61 | Mlig455_041474, Mlig455_041506 | Neo: - Age: - |
0.991 | - | - | - | - | 0.991 | - | Mlig455_041474 {REF} {Length: 589} {RNA1310_96657} {RNA815_52352} Mlig455_041506 {REF} {Length: 589} {RNA1310_96657} {RNA815_52352} |
|
4. | MligTC455_31813 | 5 | 0.11 | Mlig455_006758, Mlig455_019241 | Neo: - Age: - |
0.981 | - | - | - | - | 0.981 | - | Mlig455_006758 {REF} {Length: 3990} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=122.8]} {Smed: dd_Smed_v6_26484_0_6, dd_Smed_v6_26484_0_6, [Score=68.2, Expect=2e-13]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_6291.1} Mlig455_019241 {REF} {Length: 2474} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=112.3]} {Smed: dd_Smed_v6_26484_0_6, dd_Smed_v6_26484_0_6, [Score=62.8, Expect=1e-11]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_15609} |
|
5. | MligTC455_06252 | 20 | 0.42 | Mlig455_050158 | Neo: - Age: - |
0.97 | - | - | - | - | 0.970 | - | Mlig455_050158 {REF} {Length: 761} {NoTransDecoderORF} {RNA1310_135845} | |
6. | MligTC455_39013 | 53 | 1.1 | Mlig455_030082 | Neo: - Age: Up-Down-Down |
PLCB1 | 0.965 | - | - | - | - | 0.965 | - | Mlig455_030082 {REF} {Length: 5740} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=199.2]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=124.4]; PH domain [PF17787.3, score=120.6]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=33.9]} {Human: ENSG00000182621, PLCB1, phospholipase C beta 1, [RH, Score=826, Expect=0.0]; ENSG00000149782, PLCB3, phospholipase C beta 3, [RH, Score=824, Expect=0.0]} {Mouse: ENSMUSG00000051177, Plcb1, phospholipase C, beta 1, [RH, Score=826, Expect=0.0]; ENSMUSG00000024960, Plcb3, phospholipase C, beta 3, [RH, Score=813, Expect=0.0]} {Dmel: FBgn0262738, norpA, no receptor potential A, [Score=670, Expect=0.0]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [Score=680, Expect=0.0]} {Smed: dd_Smed_v6_3221_0_1, dd_Smed_v6_3221_0_1, [Score=724, Expect=0.0]} {RNA1509_47106} {RNA1310_7555, RNA1509_47106} {RNA1509_47106, RNA815_2033} |
7. | MligTC455_39912 | 126 | 2.62 | Mlig455_005780 | Neo: - Age: logFC(26M/2M)=0.297 |
IST1 | 0.965 | - | - | - | - | 0.965 | - | Mlig455_005780 {REF} {Length: 2185} {Pfam: Regulator of Vps4 activity in the MVB pathway [PF03398.16, score=202.0]} {Human: ENSG00000182149, IST1, IST1, ESCRT-III associated factor, [RH, Score=287, Expect=1e-95]} {Mouse: ENSMUSG00000031729, Ist1, increased sodium tolerance 1 homolog (yeast), [RH, Score=266, Expect=3e-87]} {Dmel: FBgn0035715, CG10103, [RH, Score=248, Expect=2e-79]} {Celegans: WBGene00010736, istr-1, Increased Sodium Tolerance Related, [RH, Score=244, Expect=6e-78]} {Smed: dd_Smed_v6_2006_0_1, dd_Smed_v6_2006_0_1, [RH, Score=287, Expect=2e-96]} {RNA1509_4021} {RNA1310_50949.1} {RNA815_14394.1} |
8. | MligTC455_11282 | 124 | 2.58 | Mlig455_017457, Mlig455_030936 | Neo: - |
FDXACB1 | 0.957 | - | - | - | - | 0.957 | - | Mlig455_017457 {REF} {Length: 3560} {Pfam: Domain of unknown function (DUF2431) [PF10354.11, score=97.3]; Ferredoxin-fold anticodon binding domain [PF03147.16, score=28.8]} {Human: ENSG00000255561, FDXACB1, ferredoxin-fold anticodon binding domain containing 1, [RH, Score=97.4, Expect=1e-20]} {Mouse: ENSMUSG00000037845, Fdxacb1, ferredoxin-fold anticodon binding domain containing 1, [RH, Score=104, Expect=4e-23]} {Celegans: WBGene00012768, eef-1B.2, Probable elongation factor 1-beta/1-delta 2, [RH, Score=54.7, Expect=1e-07]} {Smed: dd_Smed_v6_12236_0_1, dd_Smed_v6_12236_0_1, [RH, Score=98.2, Expect=2e-21]} {RNA1509_12220} {RNA1310_10541} {RNA815_15665} Mlig455_030936 {REF} {Length: 2975} {Pfam: Domain of unknown function (DUF2431) [PF10354.11, score=97.3]; Ferredoxin-fold anticodon binding domain [PF03147.16, score=29.2]} {Human: ENSG00000255561, FDXACB1, ferredoxin-fold anticodon binding domain containing 1, [RH, Score=97.4, Expect=2e-20]} {Mouse: ENSMUSG00000037845, Fdxacb1, ferredoxin-fold anticodon binding domain containing 1, [RH, Score=104, Expect=6e-23]} {Celegans: WBGene00012768, eef-1B.2, Probable elongation factor 1-beta/1-delta 2, [RH, Score=54.7, Expect=1e-07]} {Smed: dd_Smed_v6_12236_0_1, dd_Smed_v6_12236_0_1, [RH, Score=98.2, Expect=2e-21]} {RNA1310_10541} {RNA815_15665} |
9. | MligTC455_35307 | 38 | 0.79 | Mlig455_012667 | Neo: - Age: Up-Down-Down |
SLC12A9 | 0.955 | - | - | - | - | 0.955 | - | Mlig455_012667 {REF} {Length: 2914} {Pfam: Amino acid permease [PF00324.23, score=25.1]} {Human: ENSG00000146828, SLC12A9, solute carrier family 12 member 9, [Score=63.5, Expect=2e-12]} {Mouse: ENSMUSG00000037344, Slc12a9, solute carrier family 12 (potassium/chloride transporters), member 9, [Score=65.1, Expect=4e-13]} {Dmel: FBgn0032689, CG10413, [Score=87.0, Expect=7e-21]} {Celegans: WBGene00020207, T04B8.5, [Score=88.6, Expect=1e-21]} {Smed: dd_Smed_v6_1738_0_6, dd_Smed_v6_1738_0_6, [Score=101, Expect=3e-26]} {RNA1509_47734} {RNA1310_20621} {RNA815_24306} |